Efficacy and Safety of Viaskin Milk in Children with Immunoglobulin (IgE)-Mediated Milk Allergy in Children (MILES)

Official Title: Efficacy and Safety of Viaskin Milk in Children with Immunoglobulin (IgE)-Mediated Milk Allergy in Children (MILES)

This study is being done to see if Epicutaneous Immunotherapy with the Viaskin Milk patch is safe and to find out how well it reduces or prevents immediate allergic reactions after exposure to milk. Viaskin Milk is a skin patch that contains dry milk proteins. This study is for children ages 2 through 17 years old with cow’s milk allergy.
NCT 02223182
Makhija, Melanie M., MD
Interventional
No

Contact Information:

Melanie M Makhija, MD

Principal Investigator

888-573-1833